If you're looking for a success story in the wake of Pfizer closing its operations in Ann Arbor five years ago, look no farther than Velesco Pharma.
The Plymouth-based company, it calls the
Ann Arbor SPARK-managed
Michigan Life Science Innovation Center home, offers pharmaceutical consulting and laboratory services. It also operates a plant in Kalamazoo that makes dosage forms for clinical trials. Each year since its start, the company has experienced sustained growth.
"Velesco Pharma continues to have significant growth," says Gerry Cox, COO of
Velesco Pharma, former Velesco Pharmaceuticals. "We continue to work with ore than 75 different clients."
Velesco Pharma currently has 17 people and a few summer interns between its facilities in Plymouth and Kalamazoo. It has hired two people over the last year as it's clinical trial products and services continue to gain traction in the market. Cox expects to spend 2013 strengthening the firm's branding and business development resources to sustain its growth pattern.
"There has been significant demand," Cox says. "There has also been a lot of repeat business from existing clientele."
Source: Gerry Cox, COO of Velesco Pharma
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.